Posttreatment FDG-PET Uptake in the Supraglottic and Glottic Larynx Correlates With Decreased Quality of Life After Chemoradiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 2, 2008, Pages 386-392

  Dornfeld, Ken ^a   Hopkins, Shane ^a   Simmons, Joel ^a   Spitz, Douglas R ^a   Menda, Yusuf ^a   Graham, Michael ^a   Smith, Russell ^a   Funk, Gerry ^a   Karnell, Lucy ^a   Karnell, Michael ^a   Dornfeld, Maude ^a   Yao, Min ^a   Buatti, John ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Head and neck neoplasms; Normal tissue toxicity; Positron emission tomography; Radiotherapy

Indexed keywords

GLUCOSE; IRRADIATION; POLYETHYLENE TEREPHTHALATES; POSITRON EMISSION TOMOGRAPHY; TISSUE;

CHEMORADIOTHERAPY; NORMAL TISSUE TOXICITY; STANDARDIZED UPTAKE VALUE (SUV);

RADIOTHERAPY;

ANTIINFECTIVE AGENT; FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE TRANSPORT; HEAD AND NECK CANCER; HUMAN; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DIET; EATING; FEMALE; FLUORODEOXYGLUCOSE F18; GLOTTIS; GLUCOSE; HEAD AND NECK NEOPLASMS; HEALTH STATUS; HUMANS; LARYNX; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; QUALITY OF LIFE; RADIATION INJURIES; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 43049154399     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.09.052     Document Type: Article

References (31)

1. Dornfeld K., Simmons J.R., Karnell L., et al. Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life. Int J Radiat Oncol Biol Phys 68 (2007) 750-757
2. Eisbruch A., Lyden T., Bradford C.R., et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 23-28
3. Eisbruch A., Schwartz M., Rasch C., et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 (2004) 1425-1439
4. El-Deiry M., Funk G.F., Nalwa S., et al. Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer. Arch Otolaryngol Head Neck Surg 131 (2005) 879-885
5. Funk G.F., Karnell L.H., Smith R.B., et al. Clinical significance of health status assessment measures in head and neck cancer: What do quality-of-life scores mean?. Arch Otolaryngol Head Neck Surg 130 (2004) 825-829
6. Kotz T., Costello R., Li Y., et al. Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 26 (2004) 365-372
7. Lazarus C.L., Logemann J.A., Pauloski B.R., et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope 106 (1996) 1157-1166
8. Rosenthal D.I., Lewin J.S., and Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 24 (2006) 2636-2643
9. Shiley S.G., Hargunani C.A., Skoner J.M., et al. Swallowing function after chemoradiation for advanced stage oropharyngeal cancer. Otolaryngol Head Neck Surg 134 (2006) 455-459
10. Trotti A. Toxicity in head and neck cancer: A review of trends and issues. Int J Radiat Oncol Biol Phys 47 (2000) 1-12
11. Parsons J.T., Mendenhall W.M., Stringer S.P., et al. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: The University of Florida experience. Head Neck 15 (1993) 87-96
12. Fung K., Yoo J., Leeper H.A., et al. Vocal function following radiation for non-laryngeal versus laryngeal tumors of the head and neck. Laryngoscope 111 (2001) 1920-1924
13. Denham J.W., and Hauer-Jensen M. The radiotherapeutic injury-a complex "wound.". Radiother Oncol 63 (2002) 129-145
14. Bentzen S.M. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat Rev Cancer 6 (2006) 702-713
15. Evans E.S., Kocak Z., Zhou S.M., et al. Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer?. Cytokine 35 (2006) 186-192
16. Salvemini D., Doyle T.M., and Cuzzocrea S. Superoxide, peroxynitrite and oxidative/nitrative stress in inflammation. Biochem Soc Trans 34 (2006) 965-970
17. Averill-Bates D.A., and Przybytkowski E. The role of glucose in cellular defences against cytotoxicity of hydrogen peroxide in Chinese hamster ovary cells. Arch Biochem Biophys 312 (1994) 52-58
18. Tuttle S.W., Varnes M.E., Mitchell J.B., et al. Sensitivity to chemical oxidants and radiation in CHO cell lines deficient in oxidative pentose cycle activity. Int J Radiat Oncol Biol Phys 22 (1992) 671-675
19. Nath K.A., Ngo E.O., Hebbel R.P., et al. alpha-Ketoacids scavenge H2O2 in vitro and in vivo and reduce menadione-induced DNA injury and cytotoxicity. Am J Physiol 268 (1995) C227-C236
20. Berggren M.I., Husbeck B., Samulitis B., et al. Thioredoxin peroxidase-1 (peroxiredoxin-1) is increased in thioredoxin-1 transfected cells and results in enhanced protection against apoptosis caused by hydrogen peroxide but not by other agents including dexamethasone, etoposide, and doxorubicin. Arch Biochem Biophys 392 (2001) 103-109
21. Nomura K., Imai H., Koumura T., et al. Mitochondrial phospholipid hydroperoxide glutathione peroxidase suppresses apoptosis mediated by a mitochondrial death pathway. J Biol Chem 274 (1999) 29294-29302
22. Slane B.G., Aykin-Burns N., Smith B.J., et al. Mutation of succinate dehydrogenase subunit C results in increased O2.-, oxidative stress, and genomic instability. Cancer Res 66 (2006) 7615-7620
23. Guerrero T., Johnson V., Hart J., et al. Radiation pneumonitis: Local dose versus [(18)F]-fluorodeoxyglucose uptake response in irradiated lung. Int J Radiat Oncol Biol Phys 68 (2007) 1030-1035
24. Yao M., Dornfeld K.J., Buatti J.M., et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma-the University of Iowa experience. Int J Radiat Oncol Biol Phys 63 (2005) 410-421
25. Funk G.F., Karnell L.H., Christensen A.J., et al. Comprehensive head and neck oncology health status assessment. Head Neck 25 (2003) 561-575
26. Nakamoto Y., Zasadny K.R., Minn H., et al. Reproducibility of common semi-quantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose. Mol Imaging Biol 4 (2002) 171-178
27. Weber W.A., Ziegler S.I., Thodtmann R., et al. Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med 40 (1999) 1771-1777
28. Hicks R.J., Mac Manus M.P., Matthews J.P., et al. Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: Inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation. Int J Radiat Oncol Biol Phys 60 (2004) 412-418
29. Jingu K., Kaneta T., Nemoto K., et al. The utility of 18F-fluorodeoxyglucose positron emission tomography for early diagnosis of radiation-induced myocardial damage. Int J Radiat Oncol Biol Phys 66 (2006) 845-851
30. Love C., Tomas M.B., Tronco G.G., et al. FDG PET of infection and inflammation. Radiographics 25 (2005) 1357-1368
31. Kim G.J., Fiskum G.M., and Morgan W.F. A role for mitochondrial dysfunction in perpetuating radiation-induced genomic instability. Cancer Res 66 (2006) 10377-10383